Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder: Prospective 1-year follow-up study

Journal of Psychosomatic Research

Volumn 75, Issue 4, 2013, Pages 358-361

  Voigt, Katharina ^a   Wollburg, Eileen ^b   Weinmann, Nina ^c   Herzog, Annabel ^a   Meyer, Björn ^d   Langs, Gernot ^c   Löwe, Bernd ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c Schön Clinic Bad Bramstedt   (Germany)

^d CITY UNIVERSITY   (United Kingdom)

Author keywords

Classification of diseases; Diagnosis; Diagnostic and Statistical Manual of Mental Disorders; Somatoform disorders; Validation studies as topic

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DSM-5; DSM-IV; FEMALE; FOLLOW UP; HABIT; HEALTH BEHAVIOR; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MUSCLE WEAKNESS; PHYSICAL ACTIVITY; PREDICTIVE VALIDITY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SOMATOFORM DISORDER;

CLASSIFICATION OF DISEASES; DIAGNOSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; SOMATOFORM DISORDERS; VALIDATION STUDIES AS TOPIC;

ADULT; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PSYCHOPHYSIOLOGIC DISORDERS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SOMATOFORM DISORDERS;

EID: 84885386298     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.08.017     Document Type: Article

References (32)

1. American Psychiatric Association Somatic symptom disorder [10-3-2011.Ref Type: Electronic Citation]. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=368.
2. Voigt K, Wollburg E, Weinmann N, Herzog A, Meyer B, Langs G, et al. Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder-comparison with DSM-IV somatoform disorders and additional criteria for consideration. J Psychosom Res 2012, 73:345-350.
3. Rief W, Isaac M Are somatoform disorders 'mental disorders'? A contribution to the current debate. Curr Opin Psychiatry 2007, 20:143-146.
4. Kupfer DJ, Regier DA Current activities: report of the DSM-V Task Force 2008, [Ref Type: Electronic Citation].
5. Üstün TB, Jakob R, Celik C, Lewalle P, Kostanjsek N, Renahan M, et al. Production of ICD-11: the overall revision process 2007, World Health Organization, [www.who.int/classifications/icd/ICDRevision.pdf, 16-7-2009.Ref Type: Electronic Citation].
6. Spitzer RL, Williams JB Classification of Mental Disorders. Comprehensive Textbook of Psychiatry 1985, 591-612. Williams & Wilkins, Baltimore. 4 ed. H.I. Kaplan, B.J. Sadock (Eds.).
7. Brown RJ Psychological Mechanisms of Medically Unexplained Symptoms: An Integrative Conceptual Model. Psychol Bull 2004, 130:793-812.
8. Kirmayer LJ, Taillefer SS Somatoform Disorders. Adult psychopathology and diagnosis 1997, 333-383. John Wiley & Sons Inc, Hoboken, NJ. 3rd ed. S.M. Turner, M. Hersen (Eds.).
9. Wollburg E, Voigt K, Braukhaus C, Herzog A, Löwe B Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5. J Psychosom Res 2013, 74:18-24.
10. Wittchen HU, Zaudig M, Fydrich T Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. SKID I 1997, Hogrefe, Göttingen.
11. Gräfe K, Zipfel S, Herzog W, Löwe B Screening psychischer Störungen mit dem "Gesundheitsfragebogen für Patienten (PHQ-D)". Ergebnisse der deutschen Validierungsstudie. Diagnostica 2004, 50:171-181.
12. Kroenke K, Spitzer RL, Williams JB The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002, 64:258-266.
13. Löwe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care 2004, 42:1194-1201.
14. Löwe B, Kroenke K, Herzog W, Gräfe K Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9)13. J Affect Disord 2004, 81:61-66.
15. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004, 78:131-140.
16. Spitzer RL, Kroenke K, Williams JB, Lowe B A brief measure for assessing generalized anxiety disorder: the GAD-75. Arch Intern Med 2006, 166:1092-1097.
17. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008, 46:266-274. [Article].
18. Pilowsky I Dimensions of hypochondriasis. Br J Psychiatry 1967, 113:89-93.
19. Rief W, Ihle D, Pilger F A new approach to assess illness behaviour. J Psychosom Res 2003, 54:405-414.
20. Hiller W, Rief W, Elefant S, Margraf J, Kroymann R, Leibbrand R, et al. Dysfunktionale Kognitionen bei Patienten mit Somatisierungssyndrom. Z Klin Psychol 1997, 26:226-234.
21. Rief W, Mewes R, Martin A, Glaesmer H, Braehler E Are psychological features useful in classifying patients with somatic symptoms?. Psychosom Med 2010, 648-655.
22. Martin A, Rief W Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders2. Psychiatr Clin North Am 2011, 34:565-578.
23. Bullinger M, Kirchberger I SF-36. Fragebogen zum Gesundheitszustand. Handanweisung 1998, Hogrefe, Göttingen.
24. American Psychiatric Association Justification of criteria-somatic symptoms [28-4-2011.Ref Type: Electronic Citation]. http://www.dsm5.org/Documents/Somatic/Somatic%20Symptom%20Disorders%20description%20April%2018,%202011.pdf.
25. American Psychiatric Association Somatic Symptom Disorders [18-4-2011. Ref Type: Electronic Citation]. http://www.dsm5.org/Documents/Somatic/Somatic%20Symptom%20Disorders%20description%20April%2018,%202011.pdf.
26. Hiller W, Rief W, Fichter M Dimensional and categorical approaches to hypochondriasis. Cambridge Journals Online 2002, 707-718.
27. Rief W, Broadbent E Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev 2007, 27:821-841.
28. Riebel K, Egloff B, Witthöft M The implicit health-related self-concept in somatoform disorders. J Behav Ther Exp Psychiatry 2013, 44:335-342.
29. Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005, 162:847-855.
30. Frances A The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ 2013, 346:f1580.
31. King S A step in the wrong direction. BMJ 2013, 346:f2233.
32. Creed F The relationship between somatic symptoms, health anxiety, and outcome in medical out-patients1. Psychiatr Clin North Am 2011, 34:545-564.